Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC

Thrivent Financial for Lutherans cut its holdings in shares of Tema Oncology ETF (NASDAQ:CANC) by 84.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 147,472 shares of the company’s stock after selling 810,003 shares during the period. Thrivent Financial for Lutherans owned about 5.29% of Tema Oncology ETF worth $4,233,000 as of its most recent SEC filing.

Separately, Jane Street Group LLC boosted its holdings in Tema Oncology ETF by 59.7% in the second quarter. Jane Street Group LLC now owns 14,104 shares of the company’s stock valued at $349,000 after purchasing an additional 5,275 shares during the last quarter.

Tema Oncology ETF Stock Up 2.8%

Shares of NASDAQ CANC opened at $36.58 on Friday. Tema Oncology ETF has a fifty-two week low of $20.10 and a fifty-two week high of $37.51. The firm has a market cap of $145.95 million, a PE ratio of 20.39 and a beta of 1.00. The business has a 50 day moving average price of $35.58 and a two-hundred day moving average price of $31.29.

Tema Oncology ETF Announces Dividend

The company also recently disclosed an annual dividend, which was paid on Thursday, December 11th. Stockholders of record on Wednesday, December 10th were paid a $0.0196 dividend. This represents a dividend yield of 6.0%. The ex-dividend date of this dividend was Wednesday, December 10th.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.